Making an Impact With Preexposure Prophylaxis for Prevention of HIV Infection.


Five years ago, pivotal evidence emerged from clinical trials that preexposure prophylaxis (PrEP), using oral tenofovir disoproxil fumarate in combination with emtricitabine, was effective and safe for prevention of human immunodeficiency virus (HIV) infection [1, 2]. Subsequent work has shown high uptake and use of PrEP in demonstration settings worldwide… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.